The Zinc Ion Chelating Agent TPEN Attenuates Neuronal Death/apoptosis Caused by Hypoxia/ischemia Via Mediating the Pathophysiological Cascade Including Excitotoxicity, Oxidative Stress, and Inflammation

CNS Neurosci Ther. 2015 Sep;21(9):708-17. doi: 10.1111/cns.12428. Epub 2015 Jul 20.

Abstract

Aims: We aim to determine the significant effect of TPEN, a Zn(2+) chelator, in mediating the pathophysiological cascade in neuron death/apoptosis induced by hypoxia/ischemia.

Methods: We conducted both in vivo and in vitro experiments in this study. PC12 cells were used to establish hypoxia/ischemia model by applying oxygen-glucose deprivation (OGD). SHR-SP rats were used to establish an acute ischemic model by electrocoagulating middle cerebral artery occlusion. The effect of TPEN on neuron death/apoptosis was evaluated. In addition, the relative biomarks of excitotoxicity, oxidative stress, and inflammation reactions in hypoxia/ischemia PC12 cell model as well as in SHR-SP rat hypoxia/ischemia model were also assessed.

Results: TPEN significantly attenuates the neurological deficit, reduced the cerebral infarction area and the ratio of apoptotic neurons, and increased the expression of GluR2 in the rat hypoxia/ischemia brain. TPEN also increased blood SOD activity, decreased blood NOS activity and blood MDA and IL-6 contents in rats under hypoxia/ischemia. In addition, TPEN significantly inhibited the death and apoptosis of cells and attenuated the alteration of GluR2 and NR2 expression caused by OGD or OGD plus high Zn(2+) treatments.

Conclusions: Zn(2+) is involved in neural cell apoptosis and/or death caused by hypoxia/ischemia via mediating excitotoxicity, oxidative stress, and inflammation.

Keywords: Excitotoxicity; Free Zn2+; Hypoxia/ischemia; Inflammation; Oxidative stress; TPEN.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Apoptosis / drug effects*
  • Apoptosis / physiology
  • Brain / drug effects
  • Brain / pathology
  • Brain / physiopathology
  • Brain Ischemia / drug therapy
  • Brain Ischemia / pathology
  • Brain Ischemia / physiopathology
  • Cell Hypoxia / drug effects*
  • Cell Hypoxia / physiology
  • Chelating Agents / pharmacology
  • Disease Models, Animal
  • Ethylenediamines / pharmacology*
  • Female
  • Glucose / deficiency
  • Infarction, Middle Cerebral Artery
  • Ischemia / drug therapy*
  • Ischemia / pathology
  • Ischemia / physiopathology
  • Neuroimmunomodulation / drug effects
  • Neuroimmunomodulation / physiology
  • Neurons / drug effects*
  • Neurons / pathology
  • Neurons / physiology
  • Neuroprotective Agents / pharmacology*
  • Oxidative Stress / drug effects
  • Oxidative Stress / physiology
  • PC12 Cells
  • Rats
  • Rats, Inbred SHR
  • Receptors, AMPA / metabolism
  • Receptors, N-Methyl-D-Aspartate / metabolism
  • Zinc / metabolism

Substances

  • Chelating Agents
  • Ethylenediamines
  • Neuroprotective Agents
  • Receptors, AMPA
  • Receptors, N-Methyl-D-Aspartate
  • Glucose
  • Zinc
  • glutamate receptor ionotropic, AMPA 2
  • N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine